Ensysce Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ENSC and other ETFs, options, and stocks.About ENSC
Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses.
CEOD. Lynn Kirkpatrick
CEOD. Lynn Kirkpatrick
Employees9
Employees9
HeadquartersLa Jolla, California
HeadquartersLa Jolla, California
Founded2003
Founded2003
Employees9
Employees9
ENSC Key Statistics
Market cap5.19M
Market cap5.19M
Price-Earnings ratio-0.23
Price-Earnings ratio-0.23
Dividend yield—
Dividend yield—
Average volume734.59K
Average volume734.59K
High today$1.45
High today$1.45
Low today$1.35
Low today$1.35
Open price$1.40
Open price$1.40
Volume89.46K
Volume89.46K
52 Week high$10.96
52 Week high$10.96
52 Week low$1.26
52 Week low$1.26
Stock Snapshot
With a market cap of 5.19M, Ensysce Biosciences(ENSC) trades at $1.39. The stock has a price-to-earnings ratio of -0.23.
On 2025-12-14, Ensysce Biosciences(ENSC) stock moved within a range of $1.35 to $1.45. With shares now at $1.39, the stock is trading +3.0% above its intraday low and -4.1% below the session's peak.
Trading activity shows a volume of 89.46K, compared to an average daily volume of 734.59K.
Over the past 52 weeks, Ensysce Biosciences(ENSC) stock has traded between a high of $10.96 and a low of $1.26.
Over the past 52 weeks, Ensysce Biosciences(ENSC) stock has traded between a high of $10.96 and a low of $1.26.
People also own
Based on the portfolios of people who own ENSC. This list is generated using Robinhood data, and it’s not a recommendation.